The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of GFH018 in combination with toripalimab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).
 
Hai-Qiang Mai
No Relationships to Disclose
 
Ye Guo
Honoraria - BMS; Merck Serono; MSD; Roche
Consulting or Advisory Role - Bayer; Merck Serono; MSD; Roche
 
Muh-Hwa Yang
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Li-Tzong Chen
Leadership - ScinoPharm
Honoraria - ACT Genomics; AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Ono Pharmaceutical; PharmaEngine; SynCoreBio; TTY Biopharm
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CStone Pharmaceuticals; Ipsen; Lilly; MSD; Ono Pharmaceutical; Onward Therapeutics; Taivex Therapeutics; TTY Biopharm
Research Funding - ACT genomics (Inst); Celgene (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Polaris (Inst); SynCoreBio (Inst); TTY Biopharm (Inst)
Patents, Royalties, Other Intellectual Property - anti-alpha-enolase (ENO-1) monoclonal antibody to HuniLife Technology, Taiwan
 
Hui Mun
Speakers' Bureau - MSD
 
Yan Yang
Employment - Genfleet Therapeutics
 
Shuang Wang
Employment - Genfleet Therapeutics
 
Huaqiang Zhu
Employment - Genfleet Therapeutics
 
Haige Shen
Employment - Genfleet Therapeutics
 
Yu Wang
Employment - Genfleet Therapeutics
Stock and Other Ownership Interests - Abbisko Therapeutics